Elevation Pharmaceuticals

Aer Therapeutics

This biopharmaceutical company develops inhaled mucolytic treatments for patients with muco-obstructive lung diseases, including chronic obstructive pulmonary disease and asthma.

Breath Therapeutics

This biopharmaceutical company develops inhaled drug-aerosol therapies for patients with bronchiolitis obliterans syndrome and other severe respiratory diseases.

AirNexis Therapeutics

This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.

Expedition Therapeutics

This biotechnology company develops oral small molecule therapies for patients with serious inflammatory and respiratory diseases, including chronic obstructive pulmonary disease.

AirNexis

This clinical-stage biotechnology company develops inhaled therapies for patients with chronic obstructive pulmonary disease and other respiratory conditions.

Verona Pharma

This biopharmaceutical company develops and commercialises inhaled medicines to treat chronic respiratory diseases for adult patients with conditions such as chronic obstructive pulmonary disease.

Softhale

This company develops propellant-free soft mist inhaler devices and pharmaceutical products for patients suffering from asthma and chronic obstructive pulmonary disease.

Kither Biotech

This company develops inhaled therapies for patients with respiratory diseases such as chronic obstructive pulmonary disease and cystic fibrosis.